← Evidence map

ArticleCancers2026

Affinity Maturation and Characterization of the Novel Monoclonal Antibody (mAb) PB-223 Targeting Cancer-Specific O-Glycans Terminating with α(2,6) Sialic Acids.

Kwong Y Tsang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Affinity Maturation and Characterization of the Novel Monoclonal Antibody (mAb) PB-223 Targeting Cancer-Specific O-Glycans Terminating with α(2,6) Sialic Acids. | OpenQuestion